» Articles » PMID: 38405859

Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer

Abstract

Molecular subtypes of Small Cell Lung Cancer (SCLC) have been described based on differential expression of transcription factors (TFs) , and immune-related genes. We previously reported an additional subtype based on expression of the neurogenic TF within our SCLC Circulating tumour cell-Derived eXplant (CDX) model biobank. Here we show that ATOH1 protein was detected in 7/81 preclinical models and 16/102 clinical samples of SCLC. In CDX models, ATOH1 directly regulated neurogenesis and differentiation programs consistent with roles in normal tissues. In cultures of ATOH1-positive CDX, ATOH1 was required for cell survival. , ATOH1 depletion slowed tumour growth and suppressed liver metastasis. Our data validate ATOH1 as a oncogenic driver of SCLC with tumour cell survival and pro-metastatic functions. Further investigation to explore ATOH1 driven vulnerabilities for targeted treatment with predictive biomarkers is warranted.

References
1.
Borromeo M, Savage T, Kollipara R, He M, Augustyn A, Osborne J . ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. Cell Rep. 2016; 16(5):1259-1272. PMC: 4972690. DOI: 10.1016/j.celrep.2016.06.081. View

2.
Stewart C, Gay C, Xi Y, Sivajothi S, Sivakamasundari V, Fujimoto J . Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer. 2021; 1:423-436. PMC: 7842382. DOI: 10.1038/s43018-019-0020-z. View

3.
Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M . An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 2013; 5(6):1704-13. DOI: 10.1016/j.celrep.2013.11.020. View

4.
Pearsall S, Humphrey S, Revill M, Morgan D, Frese K, Galvin M . The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report. J Thorac Oncol. 2020; 15(12):1836-1843. PMC: 7718082. DOI: 10.1016/j.jtho.2020.07.008. View

5.
Rapa I, Volante M, Migliore C, Farsetti A, Berruti A, Scagliotti G . Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells. Prostate. 2013; 73(11):1241-9. DOI: 10.1002/pros.22679. View